You had us worried. Here I am thinking a 1.32% drop was excellent given a 2.3 on the ASX. In fact, its almost a gain!Thankfully (for CVI holders), you are right ICN looks bad.Best of luck :)
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling